Related Experiment Videos
Polymyositis: reduction of acetylcholine receptors in skeletal muscle
Abstract:
In polymyositis (PM), neither the precise target nor the mechanism of the attack against skeletal muscle have yet been defined. In this study, we report evidence of a pathologic process involving a membrane component of muscle, acetylcholine receptors (AChRs). Our results show that PM patients have significantly reduced AChRs at neuromuscular junctions, averaging 55% below control values (P less than 0.01). Incubation of cultured mammalian muscle cells with sera from PM patients significantly reduced (P less than 0.005) the number of surface AChRs and increased their rate of degradation in 7/8 cases (P less than 0.005). Similar effects were produced by purified IgG from PM patients. These results demonstrate the presence in PM patients of circulating IgG with functional effects on a component of the surface membrane of skeletal muscle. They suggest that PM and myasthenia gravis may have important features in common.
Insights
Polymyositis patients show reduced acetylcholine receptors (AChRs) at neuromuscular junctions. Patient sera containing IgG antibodies impair muscle cell AChRs, suggesting a shared mechanism with myasthenia gravis.
Area of Science:
- Neurology
- Immunology
- Muscle Biology
Background:
- Polymyositis (PM) pathogenesis remains unclear, with the specific target and mechanism attacking skeletal muscle undefined.
- Understanding the molecular basis of PM is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of acetylcholine receptors (AChRs) in the pathology of polymyositis.
- To determine if circulating antibodies in PM patients affect skeletal muscle membrane components.
Main Methods:
- Quantified acetylcholine receptors (AChRs) at neuromuscular junctions in PM patients and controls.
- Incubated cultured mammalian muscle cells with sera and purified IgG from PM patients.
- Assessed changes in surface AChR levels and degradation rates.
Main Results:
- PM patients exhibited significantly reduced AChRs at neuromuscular junctions (55% below controls).
- Sera from PM patients significantly decreased surface AChRs and increased their degradation in cultured muscle cells.
- Purified IgG from PM patients produced similar functional effects on muscle cell AChRs.
Conclusions:
- Demonstrates the presence of circulating IgG antibodies in PM patients that functionally impact skeletal muscle surface membrane components.
- Suggests that polymyositis and myasthenia gravis share common pathogenic features involving acetylcholine receptors.